Skip to main content

Table 1 Elevation of leukocytes and C-reactive protein, and degeneracy of renal function. A blood gas analysis showed metabolic acidosis, vicarious respiratory alkalosis, and hyperlactacidemia

From: Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature

Laboratory data

Complete blood count

 WBC

8080

/μL

 RBC

4.56

× 106/μL

 Hb

14.5

g/dL

 Hct

40.7

%

 Plt

18.7

× 104//μL

Blood coagulation test

 PT

80.5

%

 PT-INR

1.05

 

 APTT

29.0

seconds

Blood gas analysis

 pH

7.497

 

 PaO2

112.0

mmHg

 PaCO2

16.5

mmHg

 HCO3

12.7

mmol/L

 BE

−10.2

mEq/L

 Lactate

80.0

m/dL

Blood biochemical test

 TP

3.9

g/dL

 Alb

1.6

g/dL

 T-bil

0.2

mg/dL

 AST

29

IU/L

 ALT

14

IU/L

 LDH

387

IU/L

 CK

47

IU/L

 BUN

27.4

mg/dL

 Crea

1.01

mg/dL

 Na

130

mmol/L

 K

3.8

mmol/L

 Cl

98

mmol/L

 Ca

8.4

mg/dL

 CRP

2.37

mg/dL

  1. Alb albumin, ALT alanine aminotransferase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, BE base excess, BUN blood urea nitrogen, Ca calcium, CK creatine kinase, Cl chlorine, Crea creatinine, CRP C-reactive protein, Hb hemoglobin, HCO 3 bicarbonate, Hct hematocrit, K potassium, LDH lactate dehydrogenase, Na sodium, PaCO 2 partial pressure of carbon dioxide in arterial blood, PaO 2 partial pressure of oxygen in arterial blood, Plt platelets, PT prothrombin time, PT-INR prothrombin time-international normalized ratio, RBC red blood cells, T-bil total bilirubin, TP total protein, WBC white blood cells